Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Folate in Infection-Associated Acute Kidney Injury
NCT07377071Phase 1Not yet recruiting
- Sponsor
- The University of Hong Kong
- Start
- Apr 2026
- Primary completion
- Mar 2029
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of folic acid in acute kidney injury (AKI) (2 arms), sponsored by The University of Hong Kong. Primary endpoint: All-Cause Mortality at 1 Year. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
folic acid
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT07377071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07377071.